Grifols SA (GIFLF)
11.12
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Grifols EPS Diluted (Quarterly) : 0.1255 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharma Mar SA | 0.1033 |
| Oryzon Genomics SA | -0.0185 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 102.95M |
| Revenue (Quarterly) | 1.989B |
| Total Expenses (Quarterly) | 1.903B |
| Enterprise Value | 20.65B |
| Gross Profit Margin (Quarterly) | 36.47% |
| Profit Margin (Quarterly) | 5.18% |
| Earnings Yield | 6.36% |
| Operating Earnings Yield | 18.75% |
| Normalized Earnings Yield | 6.086 |